Washington, DC 20006-5349
HELPLINE
This session from our 2025 International Symposium on Malignant Mesothelioma was filmed on October 25th in Philadelphia, Pennsylvania. Carly Roop, RD, CSO, MA, LDN, from University of Pennsylvania presents on Nutrition and Cancer.This presentation focuses on the vital role of nutrition in supporting mesothelioma patients and their families during treatment…
This session from our 2025 International Symposium on Malignant Mesothelioma was filmed on October 25th in Philadelphia, Pennsylvania. Santhosshi Narayanan, MD, FACP from MD Anderson Cancer Center, presents on Integrative Medicine.This presentation explores the role of integrative medicine in supporting mesothelioma patients and their families throughout diagnosis, treatment, and recovery.…
Vivace Therapeutics, a company that develops cancer treatments, announced on July 30, 2025, that the U.S. Food and Drug Administration (FDA) has granted its experimental drug, VT3989, an “Orphan Drug Designation” (ODD) to treat mesothelioma, a rare and aggressive form of cancer.VT3989 is a TEAD inhibitor. It works by blocking…
In this episode of MesoTV, Julie sits down with Meso Foundation board member and estate planning attorney, Cheryl Bruner. Cheryl is a member of the mesothelioma community and lends her expertise to others so they can adequately prepare their assets. Cheryl discusses wills, power of attorney, trusts, and more. All information…
Our Patient Services Director, Julie White, RN, BSN, OCN, sits down with Michael Offin, MD to discuss a clinical trial . Dr. Offin is a Thoracic Medical Oncologist at Memorial Sloan Kettering Cancer Center. They discuss a current clinical trial for mesothelioma. Our Sponsors MesoTV is a program by the Mesothelioma…
In July 2020, the Mesothelioma UK Research Centre was established at the University of Sheffield, thanks to funding from the national charity, Mesothelioma UK. The center brings together researchers, clinicians, and PhD students, all experts in mesothelioma, to improve the care and quality of life for people living with this…
On this episode of MesoTV, our Patient Services Director, Julie White, sits down with Melissa Culligan, PhD, RN. Melissa is the Director of Thoracic Surgery Research at Temple University Hospital and the Co-Director of the Temple Health Mesothelioma and Pleural Disease Program. She goes through the details of thoracic surgery…
On this episode of MesoTV, join our Patient Services Director, Julie White, as she speaks with Marjorie Zauderer, MD, MS, FACP, and Lee Krug, MD, about the eVOLVE meso clinical trial for patients with pleural mesothelioma. Our SponsorsMesoTV is a program by the Mesothelioma Applied Research Foundation. This program is made…
Caregivers of mesothelioma patients perform crucial duties and bear considerable burdens after a loved one’s diagnosis of mesothelioma. While resources for patients are often available at treatment centers and through organizations like the Mesothelioma Applied Research Foundation, caregivers report a lack of support. Understanding and identifying the needs of caregivers…
As we dive into 2025, we want to bring new and exciting patient services and educational pieces to the mesothelioma community. We’re excited to announce the launch of our new monthly zoom series, 2025 Spotlight Sessions. Each session is designed to bring a relevant, insightful, and empowering discussion to the community.…
